292eP Exploring HER3; A potentially targetable biomarker in rare metaplastic breast cancers
ESMO Rare Cancers · 2026-03 · 5 · 100217
DOI: 10.1016/j.esmorc.2026.100217 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESMO Rare Cancers, 2026-03. Verfasst von N. Abuhadra und 13 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abuhadra, N., Adeyelu, T., Pareja, F., Chandarlapaty, S., Plitas, G., Elliott, A., Traina, T., Robson, M., Nicolaides, T., Graff, S., Lustberg, M., Norton, L., Sledge, G., & Montagna, G. (2026). 292eP Exploring HER3; A potentially targetable biomarker in rare metaplastic breast cancers. ESMO Rare Cancers, 5, 100217. https://doi.org/10.1016/j.esmorc.2026.100217
Vancouver
Abuhadra N, Adeyelu T, Pareja F, Chandarlapaty S, Plitas G, Elliott A, et al. 292eP Exploring HER3; A potentially targetable biomarker in rare metaplastic breast cancers. ESMO Rare Cancers. 2026;5:100217. doi:10.1016/j.esmorc.2026.100217
BibTeX
@article{Abuhadra2026,
author = {Abuhadra, N. and Adeyelu, T. and Pareja, F. and Chandarlapaty, S. and Plitas, G. and Elliott, A. and Traina, T.A. and Robson, M. and Nicolaides, T. and Graff, S. and Lustberg, M. and Norton, L. and Sledge, G. and Montagna, G.},
title = {292eP Exploring HER3; A potentially targetable biomarker in rare metaplastic breast cancers},
journal = {ESMO Rare Cancers},
year = {2026},
volume = {5},
pages = {100217},
doi = {10.1016/j.esmorc.2026.100217}
}
EUVIMED